SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002641
Filing Date
2020-04-28
Accepted
2020-04-28 16:01:15
Documents
7
Period of Report
2020-06-10
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241463zdef14a.htm DEF 14A 695263
2 G813071.JPG g813071.jpg GRAPHIC 14244
3 G592231.JPG g592231.jpg GRAPHIC 4604
4 G684162.JPG g684162.jpg GRAPHIC 19965
5 G721858.JPG g721858.jpg GRAPHIC 20034
6 G20702BCI001.JPG g20702bci001.jpg GRAPHIC 64333
7 G20702BCI002.JPG g20702bci002.jpg GRAPHIC 68912
  Complete submission text file 0001047469-20-002641.txt   961618
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37687 | Film No.: 20824856
SIC: 2836 Biological Products, (No Diagnostic Substances)